To analyse time trends in systemic lupus erythematosus (SLE) mortality and explore possible provincial clustering of SLE mortality in Spain (2001–2020).
Methods
We conducted an ecological study using deaths registered in SLE at the Spanish National Institute of Statistics between 2001 and 2020. Jointpoint regression models have been used to evaluate temporal trends. To analyse the spatial pattern of SLE mortality in men and women in Spain, crude rates, age-standardised mortality rates (ASMRs), smooth relative risk (RR) and posterior probabilities (PP) for RR greater than one for the period 2001–2020 were calculated. The Global Moran I index was used to assess the existence of global spatial autocorrelation. Local indicators of spatial association (LISA) and Kulldorff’s spatial scan statistic were used to identify clusters.
Results
Over the 20 years analyzed in this study, the SLE average ASMR for the period was 2.7 for women and 0.7 for men, with a sex ratio (female/male) of 3.8. In men, no province showed a RR>1. Conversely, in women, eight provinces showed values of RR> 1 with a PP greater than 0.8 (Seville, Cadiz, Huelva and Murcia in the south, Barcelona, Zaragoza, Huesca and Leon in the north). In men, neither of the two methods detected a clustering of provinces. However, in women, both methods identified a cluster of provinces located in the southwest of the country (Huelva, Cádiz, Seville and Malaga) as a cluster with significant excess mortality. In the second cluster (centred on the province of Huelva) obtained with the Kulldorff method, two more provinces were added (Badajoz and Cordoba, also located in the southwest).
Conclusions
We detected a cluster of provinces with an excess risk of female SLE mortality in the southwest of Spain.
YenEYShaheenMWooJMP, et al.46-year trends in systemic lupus erythematosus mortality in the United States, 1968 to 2013. Ann Intern Med2017; 167(11): 777–785. DOI: 10.7326/M17-0102.
3.
TianJZhangDYaoX, et al.Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis2022; 82: 351–356. DOI: 10.1136/ard-2022-223035.
4.
Duarte-GarcíaAHocaogluMValenzuela-AlmadaM, et al.Rising incidence and prevalence of systemic lupus erythematosus: a population-based study over four decades. Ann Rheum Dis2022; 81: 1260–1266. DOI: 10.1136/annrheumdis-2022-222276. annrheumdis-2022-222276.
5.
ReesFDohertyMGraingeMJ, et al.The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology2017; 56(11): 1945–1961. DOI: 10.1093/rheumatology/kex260.
6.
Reppe MoeSHaukelandHMolbergM, et al.Long-term outcome in systemic lupus erythematosus; knowledge from population-based cohorts. J Clin Med2021; 10(19): 4306. DOI: 10.3390/jcm10194306.
7.
Rúa-FigueroaILópez-LongoFJCalvo-AlénJ, et al.Registro nacional de pacientes con lupus eritematoso sistémico de la sociedad española de reumatología: objetivos y metodología. Reumatol Clínica2014; 10(1): 17–24. DOI: 10.1016/j.reuma.2013.04.013. English, Spanish.
8.
DanchenkoNSatiaJAAnthonyMS. Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus2006; 15: 308–318.
9.
CarterEEBarrSGClarkeAE. The global burden of SLE: prevalence, health disparities and socioeconomic impact. Nat Rev Rheumatol2016; 12(10): 605–620. DOI: 10.1038/nrrheum.2016.137.
10.
RuizERamalle-GómaraEElenaÁSpain RDR Working Group, et al.Trends in systemic lupus erythematosus mortality in Spain from 1981 to 2010. Lupus2014; 23(4): 431–435. DOI: 10.1177/0961203313517015.
11.
Hernández-RodríguezJCDurán-RomeroAJMuñoz-JiménezA, et al.Trends in mortality from lupus in Spain from 1980 to 2018. Lupus2020; 29(13): 1719–1726. DOI: 10.1177/0961203320952864.
12.
Gómez-RubioVLópez-QuílezA. Statistical methods for the geographical analysis of rare diseases. Rare Diseases Epidemiology2010; 686: 151–171. DOI: 10.1007/978-90-481-9485-8_10.
Joinpoint Regression Program, Version 4.9.1.0 - April 2022; Statistical Methodology and Applications Branch, Surveillance Research Program, National Cancer Institute.
KulldorffMNagarwallaN. Spatial disease clusters: detection and inference. Stat Med1995; 14: 799–810.
18.
BesagJYorkJMolliéA. Bayesian image restoration, with two applications in spatial statistics. Ann Inst Stat Math1991; 43: 1–20.
19.
RueHMartinoSChopinN. Approximate Bayesian inference for latent Gaussian models by using integrated nested laplace approximations. J Roy Stat Soc B Stat Methodol2009; 71: 319–392.
20.
R Development Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing. Available at: http://www.R-project.org/
21.
ScherlingerMMertzPSagezF, et al.Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014. Autoimmun Rev2020; 19(6): 102531. DOI: 10.1016/j.autrev.2020.102531.
22.
AlonsoMDMartínez-VázquezFRiancho-ZarrabeitiaL, et al.Sex differences in patients with systemic lupus erythematosus from Northwest Spain. Rheumatol Int2014; 34(1): 11–24. DOI: 10.1007/s00296-013-2798-9.
23.
WalshSJGilchristA. Geographical clustering of mortality from systemic lupus erythematosus in the United States: contributions of poverty, Hispanic ethnicity and solar radiation. Lupus2006; 15(10): 662–670. DOI: 10.1191/0961203306071455.
24.
GrantWB. Letter to the editor. Lupus2004; 13: 281–282.
25.
WalshSJDechelloLM. Geographical variation in mortality from systemic lupus erythematosus in the United States. Lupus2001; 10(9): 637–646. DOI: 10.1191/096120301682430230.
26.
CanneyMInduruwageDMcCandlessLC, et al.Disease-specific incident glomerulonephritis displays geographic clustering in under-serviced rural areas of British Columbia, Canada. Kidney Int2019; 96(2): 421–428. DOI: 10.1016/j.kint.2019.02.032.
27.
AlamanosYVoulgariPVSiozosC, et al.Epidemiology of systemic lupus erythematosus in northwest Greece 1982–2001. J Rheumatol2003; 30(4): 731–735.
28.
TanYYuFLongJ, et al.Frequency of systemic lupus erythematosus was decreasing among hospitalized patients from 2013 to 2017 in a national database in China. Front Med2021; 8: 648727. DOI: 10.3389/fmed.2021.648727.
ConcannonARudgeSYanJ, et al.The incidence, diagnostic clinical manifestations and severity of juvenile systemic lupus erythematosus in New Zealand Maori and Pacific Island children: the starship experience (2000−2010). Lupus2013; 22(11): 1156–1161. DOI: 10.1177/0961203313503051.
32.
Hernández-CruzBAlonsoFCalvo AlénJ, et al.AB0436 all the “Hispanics” are not equal. The severity and activity of patients with SLE Is higher in Mestizos Latin American vs. European Caucasian. Lessons from relesser. Ann Rheum Dis2016; 75: 1056.
RamalLMDe PabloRGuadixMJ, et al.HLA class II allele distribution in the Gypsy community of Andalusia, southern Spain. Tissue Antigens2001; 57: 138–143.
35.
Manzano-GameroVPardo-CabelloAJVargas-HitosJA, et al.Effect of ethnicity on clinical presentation and risk of antiphospholipid syndrome in Roma and Caucasian patients with systemic lupus erythematosus: a multicenter cross-sectional study. International Journal of Rheumatic Diseases2018; 21(11): 2028–2035. DOI: 10.1111/1756-185X.13117.
36.
RamalLMLópez-NevotMASabioJM, et al.Systemic lupus erythematosus in southern Spain: a comparative clinical and genetic study between Caucasian and gypsy patients. Lupus2004; 13(12): 934–940. DOI: 10.1191/0961203304lu2036oa.
Calvo-AlénJAlarcónGSCampbellRJr, et al.Lack of recording of systemic lupus erythematosus in the death certificates of lupus patients. Rheumatology2005; 44(9): 1186–1189. DOI: 10.1093/rheumatology/keh717.
39.
FalasinnuTRossidesMChaichianY, et al.Do death certificates underestimate the burden of rare diseases? The example of systemic lupus erythematosus mortality, Sweden, 2001–2013. Publ Health Rep2018;133(4):481-488.
40.
ThomasSLGriffithsCSmeethL, et al.Burden of mortality associated with autoimmune diseases among females in the United Kingdom. Am J Publ Health2010; 100(11): 2279–2287.
41.
SedgwickP. Understanding the ecological fallacy. BMJ2015; 351: h4773.
42.
BermudiPMMPelliniACGDinizCSG, et al.Clusters of high-risk, low-risk, and temporal trends of breast and cervical cancer-related mortality in São Paulo, Brazil, during 2000–2016. Ann Epidemiol2023; 78: 61–67. DOI: 10.1016/j.annepidem.2022.12.009.
